Changes

Jump to: navigation, search

Inflammation and cardiovascular drugs

189 bytes added, 07:53, 30 April 2009
/* Future potential areas */
# In vivo activation of '''G{alpha}q/PKC pathways'' could upregulate GRK2 expression in cardiovascular cells, thus contributing to the increased desensitization of ß-adrenergic and other GPCR systems, is of potential physiological relevance. Detailed mechanisms of regulation of GRK2 expression in different types of cells of the cardiovascular system, particularly in cardiac cell lines, and the determination of possible changes in GRK2 levels in VSMCs of patients with cardiovascular diseases are interesting fields for future research and may help to develop new therapeutic strategies based on the modulation of GRK2 expression. [http://circ.ahajournals.org/cgi/content/full/circulationaha;101/17/2083]]
 
 
==Contact Dolcera==
 
'''Samir Raiyani'''
 
'''201 A South Delaware St. #306'''
'''San Mateo, CA 94401 USA'''
'''Phone: +1-650-269-7952'''
'''Fax: +1-866-690-7517'''
'''info@dolcera.com'''